CTT Pharmaceutical insider buys 1,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CTT Pharmaceutical Holdings, Inc. (CTTH), identified as the CEO reporting person, reported a direct purchase of 1,500 shares on November 12, 2026, at $0.054 per share. The reported direct position following the purchase was 9,454,036 shares.
Insider Trade Summary
Net Buyer: 1,500 shares
Net Buy
1 txn
Insider
CTT PHARMACEUTICAL HOLDINGS, INC.
Role
CEO
Bought
1,500 shs ($81.00)
Increase in Position
0.02%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | CTTH | 1,500 | $0.054 | $81.00 |
Holdings After Transaction:
CTTH — 9,454,036 shares (Direct)
Holdings Before and After:
CTTH, 9,452,536 to 9,454,036 shares (Direct)
Key Figures
Shares purchased: 1,500 shares
Purchase price per share: $0.054 per share
Direct shares following transaction: 9,454,036 shares
3 metrics
Shares purchased
1,500 shares
Direct purchase on November 12, 2026
Purchase price per share
$0.054 per share
Direct purchase on November 12, 2026
Direct shares following transaction
9,454,036 shares
Reported position following the purchase
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.